LogicBio Therapeutics, Inc. Annual Interest Expense in USD from 2018 to 2021

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
LogicBio Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from 2018 to 2021.
  • LogicBio Therapeutics, Inc. Interest Expense for the quarter ending September 30, 2022 was $176K, a 34.8% decline year-over-year.
  • LogicBio Therapeutics, Inc. Interest Expense for the twelve months ending September 30, 2022 was $837K, a 24% decline year-over-year.
  • LogicBio Therapeutics, Inc. annual Interest Expense for 2021 was $1.07M, a 2.55% decline from 2020.
  • LogicBio Therapeutics, Inc. annual Interest Expense for 2020 was $1.1M, a 101% increase from 2019.
  • LogicBio Therapeutics, Inc. annual Interest Expense for 2019 was $546K, a 27200% increase from 2018.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2021 $1.07M -$28K -2.55% Jan 1, 2021 Dec 31, 2021 10-K 2022-03-04
2020 $1.1M +$552K +101% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-04
2019 $546K +$544K +27200% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-15
2018 $2K Jan 1, 2018 Dec 31, 2018 10-K 2020-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.